Overview
On 3 February 2010, orphan designation (EU/3/09/719) was granted by the European Commission to Italfarmaco S.p.A., Italy, for givinostat for the treatment of polycythaemia vera.
Key facts
Active substance |
Givinostat
|
Intended use |
Treatment of polycythaemia vera
|
Orphan designation status |
Positive
|
EU designation number |
EU/3/09/719
|
Date of designation |
03/02/2010
|
Sponsor |
Italfarmaco S.p.A. |
Update history
Date | Update |
---|---|
August 2023 | The sponsor’s address was updated in August 2023. |
Patients' organisations
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.
EU register of orphan medicines
The list of medicines that have received an orphan designation in the EU is available on the European Commission's website: